Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer
EGFR
The eGFR Equation
EGFR, Immunology
EGFR downregulation
EGFR-activated myofibroblasts promote metastasis of pancreatic cancer
EGFR Mutant
EGFR Resistance